You have 9 free searches left this month | for more free features.

identical

Showing 1 - 25 of 8,877

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Haplo-identical Transplantation, Transplantation Trial in Paris (Evaluate the evolution of the psychic state of the donors

Not yet recruiting
  • Haplo-identical Transplantation
  • Transplantation
  • Evaluate the evolution of the psychic state of the donors (ascendants and descendants), by means of questionnaires, within the framework of haplo-identical allograft.
  • Paris, France
    Service D'hématologie Clinique et thérapie cellulaire - Hôpital
Oct 17, 2023

Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in New York (haplo-identical cells (donor), umbilical cord blood unit

Recruiting
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndrome
  • haplo-identical cells (donor)
  • umbilical cord blood unit (CBU)
  • New York, New York
    Weill Cornell Medical College
Dec 14, 2022

Haplo-identical Transplants in Fanconi Disease

Not yet recruiting
  • Fanconi Syndrome
  • Blood sampling
  • (no location specified)
Jun 6, 2023

Reduced Intensity Fludarabine and TBI Prior to Haplo-Identical

Recruiting
  • Hematologic Malignancy
  • Fludarabine
  • Atlanta, Georgia
    Caitlin Guzowski
Sep 1, 2022

Cytomegalovirus, Adenovirus Trial in Memphis (VST infusion, CliniMACS)

Not yet recruiting
  • Cytomegalovirus
  • Adenovirus
  • VST infusion
  • CliniMACS
  • Memphis, Tennessee
    St . Jude Children's Research Hospital
Jan 9, 2023

The Heart Rhythm Twins Study

Recruiting
  • Premature Atrial Complex
  • Premature Ventricular Contraction
    • San Francisco, California
      University of California, San Francisco
    May 10, 2023

    Severe Aplastic Anemia (SAA), Hypo-Plastic Myelodysplastic Syndrome (MDS), Paroxysmal Nocturnal Hemoglobinuria (PNH) Trial run

    Recruiting
    • Severe Aplastic Anemia (SAA)
    • +2 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 28, 2023

    Allogeneic Disease, GVHD,Acute, Graft Failure Trial (WJ-MSC infusion)

    Not yet recruiting
    • Allogeneic Disease
    • +2 more
    • WJ-MSC infusion
    • (no location specified)
    May 4, 2023

    Allogenomic Mismatch Score Applied to Haplo-identical

    Completed
    • Stem Cell Transplantation
    • Haplo-identical
    • Assessment of the Allogenomic Mismatch Score (AMS)
    • Assessment of the optimised Allogenomic Mismatch Score (AMS)
    • Vandœuvre-lès-Nancy, France
      Alice Aarnink
    Feb 7, 2022

    Leukemia, Myelodysplastic Syndrome, Lymphoma Trial in New York (CliniMACS Fractionation system (Arm A), CliniMACS Fractionation

    Completed
    • Leukemia
    • +2 more
    • CliniMACS Fractionation system (Arm A)
    • +2 more
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Jul 12, 2022

    Intravenous Busulfan And Fludarabine Myeloablative Conditioning

    Completed
    • Acute Myeloid Leukemia
    • +3 more
      • (no location specified)
      Mar 16, 2022

      Absolute Uterine Factor Infertility, Cervical Cancer Trial in Gothenburg (uterus transplantation)

      Completed
      • Absolute Uterine Factor Infertility
      • Cervical Cancer
      • uterus transplantation
      • Gothenburg, Sweden
        Sahlgrenska University Hospital
      Dec 14, 2021

      Survival of Genetically Modified White Blood Cells in

      Active, not recruiting
      • HIV
        • Bethesda, Maryland
          National Institutes of Health Clinical Center, 9000 Rockville Pi
        Jan 3, 2023

        Hematopoietic Stem Cell Transplantation Trial in Nantes (IL2, Zoledronic Acid)

        Recruiting
        • Hematopoietic Stem Cell Transplantation
        • IL2
        • Zoledronic Acid
        • Nantes, France
          Nantes Uh
        Mar 29, 2022

        Hematologic Malignancies, Inborn Errors of Metabolism Disorders, Immune Deficiencies Trial in Durham (CliniMACS CD34 Reagent

        Available
        • Hematologic Malignancies
        • +2 more
        • CliniMACS CD34 Reagent System
        • Durham, North Carolina
          Duke University Medical Center
        Nov 12, 2021

        GVHD Trial in Shenzhen, Shanghai (PTCY)

        Not yet recruiting
        • GVHD
        • Shenzhen, GaungDong, China
        • +1 more
        Aug 17, 2023

        Food Allergy Trial in Melbourne (Vitamin D, )

        Active, not recruiting
        • Food Allergy
        • Vitamin D
        • placebo
        • Melbourne, Victoria, Australia
          Murdoch Childrens Research Institute
        Nov 7, 2022

        Idiopathic Pulmonary Fibrosis, Cough Trial in India (ME-015 (Suplatast Tosilate), Identical )

        Not yet recruiting
        • Idiopathic Pulmonary Fibrosis
        • Cough
        • ME-015 (Suplatast Tosilate)
        • Identical placebo
        • Guntur, Andhra Pradesh, India
        • +3 more
        Aug 1, 2023

        Multiple Myeloma Trial in San Francisco (Free light chains)

        Recruiting
        • Multiple Myeloma
        • Free light chains
        • San Francisco, California
          San Francisco General Hospital
        Mar 23, 2022

        Sickle Cell Disease Trial in Canada, United States (Alemtuzumab intravenously, low dose total body irradiation, Sirolimus)

        Recruiting
        • Sickle Cell Disease
        • Alemtuzumab intravenously, low dose total body irradiation, Sirolimus
        • Washington, District of Columbia
        • +5 more
        Mar 2, 2022

        Chronic Kidney Disease Trial in Bronx (Sodium bicarbonate)

        Completed
        • Chronic Kidney Disease
        • Sodium bicarbonate
        • Placebos
        • Bronx, New York
          Albert Einstein College of Medicine/ Montefiore Medical Center
        Aug 12, 2022

        Metabolic Syndrome Trial in Kansas City (Berberine, Identical Placebo)

        Recruiting
        • Metabolic Syndrome
        • Berberine
        • Identical Placebo
        • Kansas City, Kansas
          University of Kansas Medical Center
        May 18, 2022

        Women With Recurrent Uncomplicated Urinary Tract Infections Trial (One out of 140 predefined homeopathic medical products (HMP)

        Not yet recruiting
        • Urinary Tract Infection Chronic
        • One out of 140 predefined homeopathic medical products (HMP) in potency C200 or C1000,
        • (no location specified)
        Sep 20, 2022

        Secondary Progressive Multiple Sclerosis, Primary Progressive Multiple Sclerosis Trial in Los Angeles (Metformin 500 Mg Oral

        Recruiting
        • Secondary Progressive Multiple Sclerosis
        • Primary Progressive Multiple Sclerosis
        • Metformin 500 Mg Oral Tablet, up to 4 tablets a day
        • Placebo oral tablet identical to metformin, up to 4 tablets a day
        • Los Angeles, California
          University of California, Los Angeles
        May 2, 2022

        Abatacept, Acute-graft-versus-host Disease, Haplo-identical HCT Trial in Suzhou (Lower dose of abatacept, Higher dose of

        Recruiting
        • Abatacept
        • +3 more
        • Lower dose of abatacept
        • Higher dose of abatacept
        • Suzhou, Jiangsu, China
          the First Affiliated Hospital of Soochow University
        Jun 1, 2021